SCHEMBL12640990

SCHEMBL12640990

Cc1cc(O)cc(C)c1-c1cccc(CO)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.40
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ATM Q13315 2/20 0.37
HSP90AA1 P07900 1/20 0.37
TGFBR1 P36897 2/20 0.34
THRB P10828 1/20 0.34
CCR1 P32246 2/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
ESR2 Q92731 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ABL1 P00519 1/20 0.32
TRPV3 Q8NET8 2/20 0.32
ALOX12 P18054 1/20 0.32
MAPK10 P53779 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070847 0.88 NOS1 (0.40) HTR7MEN1KMT2ATGFBR1THRB
SCHEMBL12577773 0.86 HTR7 (0.44) HTR7TGFBR1THRBCCR1NOS1
SCHEMBL4628817 0.78 HTR7 (0.33) HTR7NOS1NOS2ALDH1A1MAPT
SCHEMBL12577789 0.76 CA12 (0.34) HTR7MAPTTRPV3FFAR1
SCHEMBL16588099 0.75 CCR1 (0.48) MEN1KMT2AHSP90AA1TGFBR1THRB
SCHEMBL9145225 0.73 CCR1 (0.46) MEN1KMT2AHSP90AA1TGFBR1THRB
SCHEMBL12578264 0.73 ALDH1A1 (0.50) MEN1KMT2AALDH1A1MAOAFFAR1
SCHEMBL9641705 0.73 CCR1 (0.64) MEN1KMT2ATGFBR1CCR1NOS2
SCHEMBL4271073 0.72 HSD17B1 (0.52) ESR2ALDH1A1MAPTPOLBHPGD
SCHEMBL12640965 0.72 TERT (0.40) HTR7MEN1KMT2AATMHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968552-B2 Oxadiazolidinedione compound ASTELLAS PHARMA INC. (JP) 2011-06-28 US disclosed
US-20090186909-A1 Oxadiazolidinedione Compound ASTELLAS PHARMA INC. (JP) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186909-A1 Oxadiazolidinedione Compound GPR119, GPR39, GPR65 HTR7 976/4885MEN1 3315/4885KMT2A 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.